Strategies to invent cardiovascular drugs targeting cardiac gap junctions

Xu Han-You 1
  • 1 Department of Emergency Medicine, Clinical Institute, Xin Ye County People’s Hospital, Henan Province, China


In order to prevent and treat cardiac diseases, the author proposed strategies to invent cardiovascular drugs targeting cardiac gap junctions through summarizing the functions, physiology and pathophysiology of cardiac gap junctions. The 5 principle strategies to invent cardiovascular drugs that are suggested have great potentialities to be used as novel proposals to treat and prevent cardiac diseases.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] Wit A.L., Duffy H.S., Drug Development for Treatment of Cardiac Arrhythmias. Targeting the Gap Junctions. Am. J. Physiol. Heart Circ. Physiol., 2007, (in press)

  • [2] Kanno S., Saffitz JE., The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc. Pathol., 2001, 10, 169–177.

  • [3] Teunissen B.E., Bierhuizen M.F., Transcriptional control of myocardial connexins. Cardiovasc. Res., 2004, 62, 246–255

  • [4] Dhein S., Polontchouk L., Salameh A., Haefliger J.A., Pharmacological modulation and differential regulation of the cardiac gap junction proteins connexin 43 and connexin 40. Biol. Cell., 2002, 94, 409–422

  • [5] Garcia-Dorado D., Ruiz-Meana M., Padilla F., Rodriguez-Sinovas A., Mirabet M., Gap junctionmediated intercellular communication in ischemic preconditioning. Cardiovasc. Res., 2002, 55, 456–465


Journal + Issues